CLINICAL_TRIALS
trial_result
· 2025-10-27
Clinical Trial Update: The Women TAF-FTC Benchmark Study [Phase 2, Phase 3]
Summary
A Phase 2/3 trial evaluating the emtricitabine/tenofovir alafenamide combination in women has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-10-27